CHR: Chr. Hansen Holding A/S - Summary | Jitta

Chr. Hansen Holding A/S

DNK:CHR

Notice
Stock data is unavailable or the company’s delisted.
Price
kr549.60
Loss Chance
44.5%
6.19JITTA SCORE
359.90%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (43)
Recent Business Performance (61)
Financial Strength (83)
Return to Shareholders (61)
Competitive Advantage (68)
Jitta Signs
Revenue and EarningEarning decline from 2020-2023
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
6.19
359.90%
5.91
79.81%
5.17
131.71%
COMPANY DESCRIPTION
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark. As of January 29, 2024, Chr. Hansen Holding A/S operates as a subsidiary of Novozymes A/S.